https://www.globaldata.com/newsletter/details/novartis-bags-paediatric-fda-label-expansion-for-lutathera_302438/?newsletterdate=2024-04-25&hubspotcategory=gd-pharma-prospects-daily&utm_source=website&utm_medium=top_navigation&utm_content=other_daily_news_articles&utm_campaign=type2_pharma
@Phaedrus
An example of label expansion by from our buddies at Novartis
Question- we have run adult trials with a less potent product- could that data along with EAP real world evidence contribute to an expansion into adults?
Reg
https://www.globaldata.com/newsletter/details/novartis-bags-paedi...
-
- There are more pages in this discussion • 374 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.065(4.69%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.50 | $1.38 | $7.016M | 4.856M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10425 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 44243 | 5 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |